Literature DB >> 33433832

The circular RNA circSlc7a11 promotes bone cancer pain pathogenesis in rats by modulating LLC-WRC 256 cell proliferation and apoptosis.

Han-Wen Chen1,2, Xiao-Xia Zhang2, Zhu-Ding Peng2, Zu-Min Xing2, Yi-Wen Zhang2, Ya-Lan Li3.   

Abstract

Treatment of bone cancer pain (BCP) caused by bone metastasis in advanced cancers remains a challenge in clinical oncology, and the underlying mechanisms of BCP are poorly understood. This study aimed to investigate the pathogenic roles of circular RNAs (circRNAs) in regulating cancer cell proliferation and BCP development. Eight differentially expressed circRNAs in the rat spinal cord were validated by agarose gel electrophoresis and Sanger sequencing. Expression of circRNAs and mRNAs was detected by quantitative RT-PCR. MTS assay and flow cytometry were performed to analyze cell proliferation and apoptosis, respectively. Differentially expressed mRNA profiles were characterized by deep RNA sequencing, hierarchical clustering, and functional categorization. The interactions among circRNAs, microRNAs (miRNAs), and mRNAs were predicted using TargetScan. Additionally, western blot was performed to determine the protein levels of Pax8, Isg15, and Cxcl10. Multiple circRNAs were differentially expressed in the spinal cords of BCP model rats; of these, circSlc7a11 showed the greatest increase in expression. The overexpression of circSlc7a11 significantly promoted cell proliferation and repressed apoptosis of LLC-WRC 256 and UMR-106 cells, whereas circSlc7a11 silencing produced the opposite effects. Altered expression of circSlc7a11 also induced substantial changes in the mRNA expression profiles of LLC-WRC 256 cells; these changes were linked to multiple apoptotic processes and signaling pathways, such as the chemokine signaling pathway, and formed a complex circRNA/miRNA/mRNA network. Additionally, Pax8, Isg15, and Cxc110 protein level in LLC-WRC 256 cells was consistent with the mRNA results. The circRNA circSlc7a11 regulates rat BCP development by modulating LLC-WRC 256 cell proliferation and apoptosis through multiple-signaling mechanisms.

Entities:  

Keywords:  Apoptosis; Bone cancer pain; LLC-WRC 256; Proliferation; circSlc7a11

Mesh:

Substances:

Year:  2021        PMID: 33433832      PMCID: PMC7940317          DOI: 10.1007/s11010-020-04020-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  32 in total

Review 1.  CXCR3: latest evidence for the involvement of chemokine signaling in bone cancer pain.

Authors:  Genhua Guo; Feng Gao
Journal:  Exp Neurol       Date:  2015-02-11       Impact factor: 5.330

Review 2.  Targeting glia for bone cancer pain.

Authors:  Ya-Qun Zhou; Zheng Liu; Hui-Quan Liu; Dai-Qiang Liu; Shu-Ping Chen; Da-Wei Ye; Yu-Ke Tian
Journal:  Expert Opin Ther Targets       Date:  2016-07-27       Impact factor: 6.902

Review 3.  Circular RNAs: analysis, expression and potential functions.

Authors:  Steven P Barrett; Julia Salzman
Journal:  Development       Date:  2016-06-01       Impact factor: 6.868

4.  Interventional treatments for metastatic bone cancer pain.

Authors:  Vivek Sindhi; Michael Erdek
Journal:  Pain Manag       Date:  2019-05-29

Review 5.  Bone cancer pain: from mechanism to therapy.

Authors:  Patrick W Mantyh
Journal:  Curr Opin Support Palliat Care       Date:  2014-06       Impact factor: 2.302

6.  WNT signaling underlies the pathogenesis of neuropathic pain in rodents.

Authors:  Yan-Kai Zhang; Zhi-Jiang Huang; Su Liu; Yue-Peng Liu; Angela A Song; Xue-Jun Song
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

Review 7.  Chemokines and Their Receptors: Potential Therapeutic Targets for Bone Cancer Pain.

Authors:  Ya-Qun Zhou; Heng-Yi Gao; Xue-Hai Guan; Xun Yuan; Guang-Guang Fang; Yuan Chen; Da-Wei Ye
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 8.  Bone cancer pain: causes, consequences, and therapeutic opportunities.

Authors:  Patrick Mantyh
Journal:  Pain       Date:  2013-07-31       Impact factor: 6.961

9.  Activation of spinal chemokine receptor CXCR3 mediates bone cancer pain through an Akt-ERK crosstalk pathway in rats.

Authors:  Xue-Hai Guan; Qiao-Chu Fu; Dai Shi; Hui-Lian Bu; Zhen-Peng Song; Bing-Rui Xiong; Bin Shu; Hong-Bing Xiang; Bing Xu; Anne Manyande; Fei Cao; Yu-Ke Tian
Journal:  Exp Neurol       Date:  2014-10-02       Impact factor: 5.330

10.  CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord.

Authors:  Wen Shen; Xue-Ming Hu; Yan-Nan Liu; Yuan Han; Li-Ping Chen; Chen-Chen Wang; Chao Song
Journal:  J Neuroinflammation       Date:  2014-04-16       Impact factor: 8.322

View more
  3 in total

1.  Next-Generation Sequencing of Circular RNAs Reveals the Molecular Mechanisms of Chondrogenic Differentiation in Human Adipose-derived Stem Cells.

Authors:  Simin Luo; Wuji Li; Wenrui Wu; Qiping Shi
Journal:  Cell Biochem Biophys       Date:  2022-03-07       Impact factor: 2.989

Review 2.  Circular RNAs modulate Hippo-YAP signaling: functional mechanisms in cancer.

Authors:  Javeria Qadir; Feiya Li; Burton B Yang
Journal:  Theranostics       Date:  2022-05-16       Impact factor: 11.600

Review 3.  DNA Methylation and Non-Coding RNAs during Tissue-Injury Associated Pain.

Authors:  Jahanzaib Irfan; Muhammad Rizki Febrianto; Anju Sharma; Thomas Rose; Yasamin Mahmudzade; Simone Di Giovanni; Istvan Nagy; Jose Vicente Torres-Perez
Journal:  Int J Mol Sci       Date:  2022-01-11       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.